Application
A. Western blot analysis on HepG2 cell lysates using anti-p53 Phospho (pS46) RabMAb (Cat. #AJ1573i), 1:2000 dilution. Cells were either (A) untreated (B) treated with etopside.
Application
B. Immunohistochemical analysis of human ovarian adenocarcinoma using anti-p53 Phospho (pS46) RabMAb (Cat. #AJ1573i)